Sensitivity and specificity of NT-proBNP to detect heart failure at post mortem examination

International Journal of Legal Medicine

Volumn 125, Issue 6, 2011, Pages 849-856

  Sabatasso, Sara ^a   Vaucher, Paul ^a   Augsburger, Marc ^a   Donzé, Nicolas ^b   Mangin, Patrice ^a   Michaud, Katarzyna ^a  

^a UNIVERSITY CENTER OF LEGAL MEDICINE   (Switzerland)

^b Hopitaux Valaisans   (Switzerland)

Author keywords

Biomarkers; Forensic autopsy; Heart failure; NT proBNP. Natriuretic peptides

Indexed keywords

BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PRO BRAIN NATRIURETIC PEPTIDE (1 76); PRO-BRAIN NATRIURETIC PEPTIDE (1-76);

AGED; ARTICLE; AUTOPSY; BLOOD; CAUSE OF DEATH; FEMALE; HEART FAILURE; HUMAN; LUMINESCENCE; MALE; MIDDLE AGED; PREDICTIVE VALUE; SENSITIVITY AND SPECIFICITY;

AGED; AUTOPSY; BIOLOGICAL MARKERS; CAUSE OF DEATH; FEMALE; HEART FAILURE; HUMANS; LUMINESCENT MEASUREMENTS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 83155180635     PISSN: 09379827     EISSN: 14371596     Source Type: Journal    
DOI: 10.1007/s00414-011-0581-6     Document Type: Article

References (43)

1. Munagala VK, Burnett JC Jr, Redfield MM (2004) The natriuretic peptides in cardiovascular medicine. Curr Probl Cardiol 29:707-769 (Pubitemid 39488317)
2. Clerico A, Emdin M (2004) Diagnostic accuracy and prognostic relevance of the measurement of cardiac natriuretic peptides: a review. Clin Chem 50:33-50 (Pubitemid 38125697)
3. de Lemos JA, McGuire DK, Drazner MH (2003) B-type natriuretic peptide in cardiovascular disease. Lancet 362:316-322 (Pubitemid 36936846)
4. Hall C (2004) Essential biochemistry and physiology of (NT-pro) BNP. Eur J Heart Fail 6:257-260 (Pubitemid 38253043)
5. Richards AM, Nicholls MG, Yandle TG et al (1998) Plasma Nterminal pro-brain natriuretic peptide and adrenomedullin: new neurohormonal predictors of left ventricular function and prognosis after myocardial infarction. Circulation 97:1921-1929
6. Omland T, Aakvaag A, Bonarjee VV et al (1996) Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction. Comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93:1963-1969
7. Schulz H, Langvik TA, Lund Sagen E et al (2001) Radioimmunoassay for N-terminal probrain natriuretic peptide in human plasma. Scand J Clin Lab Invest 61:33-42 (Pubitemid 32240871)
8. Zhu BL, Ishikawa T, Michiue T et al (2007) Postmortem pericardial natriuretic peptides as markers of cardiac function in medico-legal autopsies. Int J Legal Med 121:28-35 (Pubitemid 46009469)
9. Pfister R, ScholzM, Wielckens K et al (2004) Use of NT-proBNP in routine testing and comparison to BNP. Eur J Heart Fail 6:289-293 (Pubitemid 38253047)
10. Kragelund C, Gronning B, Kober L et al (2005) N-Terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease. N Engl J Med 352:666-675 (Pubitemid 40239214)
11. Nowatzke WL, Cole TG (2003) Stability of N-terminal pro-brain natriuretic peptide after storage frozen for one year and after multiple freeze-thaw cycles. Clin Chem 49:1560-1562 (Pubitemid 37011760)
12. Michaud K, Augsburger M, Donzé N et al (2008) Evaluation of postmortem measurement of NT-proBNP as a marker for cardiac function. Int J Legal Med 122:415-420
13. Recommendation no. R (99) 3 of the Committee of Ministers to member states on the harmonization of medico-legal autopsy rules (2000) Forensic Sci Int 111:5-58
14. Winek CL, Wahba WW, Winek CL Jr et al (2001) Drug chemical blood level data 2001. Forensic Sci Int 122:107-123 (Pubitemid 32979233)
15. Jensen KT, Carstens J, Ivarsen P et al (1997) A new, fast and reliable radioimmunoassay of brain natriuretic peptide in human plasma. Reference values in healthy subjects and in patients with different diseases. Scand J Clin Lab Invest 57:529-540 (Pubitemid 27443526)
16. CowieMR, Jourdain P, Maisel A et al (2003) Clinical applications of B-type natriuretic peptide (BNP) testing. Eur Heart J 24:1710-1718 (Pubitemid 37236859)
17. Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159-174 (Pubitemid 8054849)
18. Zweig MH, Campbell G (1993) Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem 8:561-577 (Pubitemid 23118304)
19. Seino Y, Ogawa A, Yamashita T et al (2004) Application of NTproBNP and BNP measurements in cardiac care: a more discerning marker for the detection and evaluation of heart failure. Eur J Heart Fail 6:295-300 (Pubitemid 38253048)
20. Groenning BA, Nilsson JC, Sondergaard L et al (2002) Detection of left ventricular enlargement and impaired systolic function with plasma N-terminal pro brain natriuretic peptide concentrations. Am Heart J 143:923-929 (Pubitemid 34595355)
21. Schelton RJ, Clark AL, Goode K et al (2006) The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Eur Heart J 27:2353-2361 (Pubitemid 44461764)
22. Mikkelsen KV, Bie P, Møller JE et al (2006) The diagnostic utility of N-terminal pro-B-type natriuretic peptide for the detection of major structural heart disease in patients with atrial fibrillation. Int J Cardiol 110:324-333
23. Goode KM, Clark AL, Cleland JGF (2008) Ruling out heart failure in primary care: the cost-benefit of pre-screening using NTproBNP and QRS width. Int J Cardiol 130:426-437
24. Talwar S, Squire IB, Davies JE et al (1999) Plasma N-terminal pro-brain natriuretic peptide and the ECG in the assessment of left-ventricular systolic dysfunction in a high risk population. Eur Heart J 20:1736-1744
25. Apple FS, Jesse RL, Newby LK et al (2007) National academy of clinical biochemistry and IFCC committee for standardization of markers of cardiac damage laboratory medicine practice guidelines: analytical issues for biochemical markers of acute coronary syndromes. Clin Chem 53:547-551 (Pubitemid 46580222)
26. Morrow DA, Cannon CP, Jesse RL (2007) National academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes. Clin Chem 53:552-574 (Pubitemid 46580223)
27. Ellingsen CL, Hetland Ø (2004) Serum concentrations of cardiac troponin T in sudden death. Am J Forensic Med Pathol 25:213-215 (Pubitemid 39129599)
28. Zhu BL, Ishikawa T, Michiue T et al (2006) Postmortem cardiac troponin T levels in the blood and pericardial fluid. Part 2: analysis for application in the diagnosis of sudden cardiac death with regard to pathology. Leg Med (Tokyo) 8:94-101 (Pubitemid 43243309)
29. Peter J, Kirchner A, Kuhlisch E et al (2006) The relevance of the detection of troponins to the forensic diagnosis of cardiac contusion. Forensic Sci Int 160:127-133 (Pubitemid 44037260)
30. Vargas SO, Grudzien C, Tanasijevic MJ (2008) Postmortem cardiac troponin-I levels predict intramyocardial damage at autopsy. J Thromb Thrombolysis 26:132-137
31. Davies SJ, Gaze DC, Collinson PO (2005) Investigation of cardiac troponins in postmortem subjects: comparing antemortem and postmortem levels. Am J Forensic Med Pathol 26:213-215 (Pubitemid 41266576)
32. Ingham AL, Byard RW (2009) The potential significance of elevated vitreous sodium levels at autopsy. J Forensic Leg Med 16:437-440
33. Fucci N, De Giovanni N, De Giorgio F et al (2006) An evaluation of the Cozart RapiScan system as an on-site screening tool for drugs of abuse in a non-conventional biological matrix: vitreous humor. Forensic Sci Int 156:102-105 (Pubitemid 43061250)
34. Teixeira HM, Reis F, Proença P et al (2004) Vitreous humour as a complementary sample to blood for the detection/confirmation of diazepam: ante-mortem and post-mortem studies in an animal model. Hum Exp Toxicol 23:571-577 (Pubitemid 40096860)
35. De Letter EA, Piette MH (1998) Can routinely combined analysis of glucose and lactate in vitreous humour be useful in current forensic practice? Am J Forensic Med Pathol 19:335-342 (Pubitemid 29024541)
36. De Letter EA, De Paepe P, Clauwaert KM et al (2000) Is vitreous humour useful for the interpretation of 3, 4-methylenedioxymethamphetamine (MDMA) blood levels? Experimental approach with rabbits. Int J Leg Med 114:29-35 (Pubitemid 32153967)
37. Winek CL, Esposito FM (1981) Comparative study of ethanol levels in blood versus bone marrow, vitreous humor, bile and urine. Forensic Sci Int 17:27-36 (Pubitemid 11141606)
38. Luna A, Carmona A, Villanueva E (1983) The postmortem determination of CK isozymes in the pericardial fluid in various causes of death. Forensic Sci Int 22:23-30 (Pubitemid 13050440)
39. Perez-Cárceles MD, Osuna E, Vieira DN et al (1995) Biochemical assessment of acute myocardial ischaemia. J Clin Pathol 48:124-128
40. Gibson AT, Segal MB (1978) A study of the composition of pericardial fluid, with special reference to the probable mechanism of fluid formation. J Physiol 277:367-377 (Pubitemid 8369963)
41. Gibson AT, Segal MB (1978) A study of the routes by which protein passes from the pericardial cavity to the blood in rabbits. J Physiol 280:423-433
42. Fracasso T, Karger B, Pfeiffer H et al (2009) Immunohistochemical identification of prevalent right ventricular ischemia causing right heart failure in cases of pulmonary fat embolism. Int J Leg Med. doi:10.1007/s00414- 009-0382-3
43. Fracasso T, Pfeiffer H, Sauerland C et al (2010) Morphological identification of right ventricular failure in cases of fatal pulmonary thromboembolism. Int J Leg Med. doi:10.1007/ s00414-010-0486-9